Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Regan Fong

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Journal of Dermatological Treatment|April 18, 2015
Safety of alitretinoin for severe refractory chronic hand eczema: Clinical studies and postmarketing surveillanceMarc Morris, Lorrie Schifano, Regan Fong, et al.
Brain Research. Cognitive Brain Research|February 19, 2003
Event-related brain potentials during auditory and visual word recognition memory tasksJürgen Kayser, Regan Fong, Craig E Tenke, et al.
Journal of Child and Adolescent Psychopharmacology|March 24, 2006
An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorderRay Berard, Regan Fong, David J Carpenter, et al.
Clinical and Translational Science|December 5, 2020
Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of Vixotrigine in Healthy VolunteersHimanshu Naik, Deb J Steiner, Mark Versavel, et al.
Journal of Clinical Pharmacology|August 26, 2018
Effects of a State- and Use-Dependent Nav1.7 Channel Blocker on Ambulatory Blood Pressure: A Randomized, Controlled Crossover StudyRegan Fong, Charles H Ballow, Himanshu Naik, et al.
The Journal of Clinical Psychiatry|March 4, 2011
Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trialsDavid J Carpenter, Regan Fong, John E Kraus, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 11, 2016
Evaluation of the safety, pharmacokinetics, pharmacodynamics, and drug-drug interaction potential of a selective Lp-PLA2 inhibitor (GSK2647544) in healthy volunteers
Kai Wu, Jianfeng Xu, Regan Fong, et al.
Journal of Affective Disorders|May 15, 2009
Clinical features of patients with treatment-emergent suicidal behavior following initiation of paroxetine therapyJohn E Kraus, Joseph P Horrigan, David J Carpenter, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|April 8, 2006
Analysis of electrocardiographic data following use of paroxetine in pediatric depression and obsessive-compulsive disorderStan Krulewicz, David J Carpenter, Regan Fong, et al.
Journal of Child and Adolescent Psychopharmacology|March 24, 2006
Evaluation of suicidal thoughts and behaviors in children and adolescents taking paroxetineAlan Apter, Alan Lipschitz, Regan Fong, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Journal of Dermatological Treatment|April 18, 2015
Safety of alitretinoin for severe refractory chronic hand eczema: Clinical studies and postmarketing surveillanceMarc Morris, Lorrie Schifano, Regan Fong, et al.
Brain Research. Cognitive Brain Research|February 19, 2003
Event-related brain potentials during auditory and visual word recognition memory tasksJürgen Kayser, Regan Fong, Craig E Tenke, et al.
Journal of Child and Adolescent Psychopharmacology|March 24, 2006
An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorderRay Berard, Regan Fong, David J Carpenter, et al.
Clinical and Translational Science|December 5, 2020
Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of Vixotrigine in Healthy VolunteersHimanshu Naik, Deb J Steiner, Mark Versavel, et al.
Journal of Clinical Pharmacology|August 26, 2018
Effects of a State- and Use-Dependent Nav1.7 Channel Blocker on Ambulatory Blood Pressure: A Randomized, Controlled Crossover StudyRegan Fong, Charles H Ballow, Himanshu Naik, et al.
The Journal of Clinical Psychiatry|March 4, 2011
Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trialsDavid J Carpenter, Regan Fong, John E Kraus, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 11, 2016
Evaluation of the safety, pharmacokinetics, pharmacodynamics, and drug-drug interaction potential of a selective Lp-PLA2 inhibitor (GSK2647544) in healthy volunteers
Kai Wu, Jianfeng Xu, Regan Fong, et al.
Journal of Affective Disorders|May 15, 2009
Clinical features of patients with treatment-emergent suicidal behavior following initiation of paroxetine therapyJohn E Kraus, Joseph P Horrigan, David J Carpenter, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|April 8, 2006
Analysis of electrocardiographic data following use of paroxetine in pediatric depression and obsessive-compulsive disorderStan Krulewicz, David J Carpenter, Regan Fong, et al.
Journal of Child and Adolescent Psychopharmacology|March 24, 2006
Evaluation of suicidal thoughts and behaviors in children and adolescents taking paroxetineAlan Apter, Alan Lipschitz, Regan Fong, et al.
Pageof 2